Erlotinib and diarrhoea 
Erlotinib and diarrhoea Patient Reports February 11, 2012
Erlotinib Side Effects Report #5098898-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 17, 2006. Female patient, 56 years of age, weighting 182.0 lb, was diagnosed with squamous cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anxiety
, dehydration, diarrhoea, dizziness , dysphagia, epistaxis, hypoaesthesia, hypoglycaemia, mouth haemorrhage. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with ZANTAC, INDERAL LA, GLUCOPHAGE, MIRAPEX, LOPID, GLIPIZIDE, FISH OIL, WELLBUTRIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6025814-6
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 17, 2008. Male patient, 66 years of age, weighting 194.0 lb, was diagnosed with renal cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, fatigue, hypotension, renal failure. Erlotinib dosage: (50 MG,QD),ORAL. During the same period patient was treated with SUNITINIB MALATE, LIPITOR, LISINOPRIL, MINOCYCLINE, NIACIN, PANTOPRAZOLE, POTASSIUM CHLORIDE, ALEVE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5792705-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on June 10, 2008. Male patient, 69 years of age, weighting 153.0 lb, was diagnosed with renal cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypotension, myocardial infarction. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with RAPAMUNE, BENZACLIN, DICYCLOMINE, LOMOTIL, DOXAZOSIN, FINASTERIDE, FUROSEMIDE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5107075-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 29, 2006. Male patient, 57 years of age, weighting 206.0 lb, was diagnosed with rectal cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, chills, colitis, diarrhoea, haematocrit decreased, haemoglobin decreased, infection
, lymphopenia. Erlotinib dosage: 50 MG, DAYS 1-14 OF CYCLE (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, FLUOROURACIL, ATIVAN, COMPAZINE, FOLIC ACID, HYDROCHLOROTHIAZIDE, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5803938-3
Erlotinib side effect was reported by a Physician from SPAIN on June 18, 2008. Female patient, 76 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, gastrointestinal toxicity, malignant neoplasm progression, nausea
, pancreatic carcinoma. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE, LOPERAMIDA, EPOETIN BETA, NEUPOGEN, BUPRENORFINE HYDROCHLORIDE, METAMIZOL MAGNESIUM, FENTANILO, ENOXAPARIN. Patient was hospitalized. Patient died on 02/09/2008.Erlotinib Side Effects Report #5203396-6
Erlotinib side effect was reported by a Physician from PERU on Dec 21, 2006. Male patient, 74 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, dehydration, diarrhoea, haemoglobin decreased, hypovolaemic shock, malabsorption, no therapeutic response. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE. Patient was hospitalized and became disabled. Patient died.
Erlotinib Side Effects Report #5380022-7
Erlotinib side effect was reported by a Physician from PERU on June 18, 2007. Female patient, 54 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, aspartate aminotransferase increased, blood glucose increased, dehydration, diarrhoea, nausea
, prothrombin time prolonged, pyrexia. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, GLYBURIDE, METFORMIN, ALPRAZOLAM, ACETAMINOPHEN, OMEPRAZOLE, TRAMADOL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5372695-X
Erlotinib side effect was reported by a Physician from JAPAN on June 05, 2007. Male patient, 77 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain lower, anorexia, cardiomegaly, cholangitis, diarrhoea, emphysema, faecaloma, hypoglycaemia, interstitial lung disease. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with GEMCITABINE, DEXAMETHASONE PHOSPHATE, OXYCODONE, SULINDAC, TEPRENONE, RABEPRAZOLE, FUROSEMIDE, AMLODIPINE BESYLATE. Patient recovered.
Erlotinib Side Effects Report #5404736-5
Erlotinib side effect was reported by a Physician from JAPAN on July 17, 2007. Male patient, 77 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain lower, anorexia, blood glucose increased, cardiomegaly, cholangitis, diarrhoea, emphysema, faecaloma, hypoglycaemia. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with GEMCITABINE, DEXAMETHASONE PHOSPHATE, OXYCODONE, SULINDAC, TEPRENONE, RABEPRAZOLE, FUROSEMIDE, AMLODIPINE BESYLATE. Patient recovered.
Erlotinib Side Effects Report #5531268-6
Erlotinib side effect was reported by a Physician from JAPAN on Nov 12, 2007. Male patient, 77 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, aphasia
, cholangitis, diarrhoea, emphysema, faecaloma, granuloma, hypoglycaemia, interstitial lung disease. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with GEMCITABINE, DEXAMETHASONE PHOSPHATE, OXYCODONE, SULINDAC, TEPRENONE, RABEPRAZOLE, FUROSEMIDE, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5148570-2
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Sept 21, 2006. Male patient, 74 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ascites, bacterial infection
, biliary sepsis, blood culture positive, candidiasis, cardiovascular disorder, central line infection, diarrhoea, epistaxis. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with GEMCITABINE, BEVACIZUMAB, CAPECITABINE, METOCLOPRAMIDE, LANSOPRAZOLE, CHLORPROMAZINE, BENDROFLUAZIDE, CREAM NOS. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5268193-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 14, 2007. Male patient, weighting 205.0 lb, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, diarrhoea, heart rate increased, pyrexia, respiratory rate increased. Erlotinib dosage: 150 MG ONCE A DAY PO. During the same period patient was treated with XELODA, PANCREASE, PREVACID, ZOLOFT, IMODIUM, ZOFRAN, LOMOTIL, TINCTURE OF OPIUM. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5744848-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 02, 2008. Female patient was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypokalaemia, vomiting. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with EVEROLIMUS, AUGMENTIN, CELEXA, CENTRUM, ESTROGEN PATCH, LORTAB, NEXIUM, ZOFRAN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5330419-6
Erlotinib side effect was reported by a Physician from AUSTRIA on Apr 30, 2007. Female patient, 66 years of age, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, ileus. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient recovered.
Erlotinib Side Effects Report #4928557-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 08, 2006. Female patient, 65 years of age, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal distension, diarrhoea, dyspnoea, pleural effusion, pneumonia
, pulmonary embolism . Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5481997-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 10, 2007. Female patient, 71 years of age, weighting 166.9 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood chloride decreased, blood glucose increased, blood sodium decreased, diarrhoea, haemoglobin decreased, heart rate increased, leukopenia, mucosal inflammation, neutrophil count decreased. Erlotinib dosage: 100 MG. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL, ACIPHEX, IMITREX, NAPROXEN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5908423-6
Erlotinib side effect was reported by a Physician from UNITED STATES on Sept 15, 2008. Male patient, 66 years of age, weighting 186.1 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, dysphagia, leukopenia, lip pain, mucosal inflammation, oesophagitis, oral pain. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, FLUOROURACIL, CARBOPLATIN, PACLITAXEL, OXYCODONE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5775135-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 28, 2008. Male patient, 64 years of age, weighting 138.9 lb, was diagnosed with oesophageal carcinoma, multiple myeloma
and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: choking , dehydration, diarrhoea, epistaxis, nausea , oesophagitis, oral pain, weight decreased. Erlotinib dosage: (100 MG,QD) ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5797454-5
Erlotinib side effect was reported by a Physician from UNITED STATES on June 12, 2008. Male patient, 64 years of age, weighting 138.9 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: choking
, dehydration, diarrhoea, epistaxis, nausea , odynophagia, oesophagitis, oral pain. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5407966-1
Erlotinib side effect was reported by a Physician from UNITED STATES on July 19, 2007. Male patient, 60 years of age, weighting 166.4 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest discomfort, chest pain
, dehydration, diarrhoea, dyspnoea, hyperglycaemia, hyperhidrosis, hyponatraemia, hypotension. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5420941-6
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 03, 2007. Male patient, 60 years of age, weighting 166.4 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, chest pain
, dehydration, diarrhoea, dyspnoea, hyperglycaemia, hyperhidrosis, hyponatraemia, hypotension. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6063552-4
Erlotinib side effect was reported by a Physician from UNITED STATES on Jan 16, 2009. Male patient, 58 years of age, weighting 186.1 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, dysphagia, febrile neutropenia, penis disorder
, vomiting, white blood cell count decreased. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6083750-3
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 03, 2009. Male patient, 58 years of age, weighting 186.1 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, dehydration, diarrhoea, dysphagia, febrile neutropenia, penis disorder
, vomiting, white blood cell count decreased. Erlotinib dosage: 100 MG, DAYS 1-42, ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL, ROXICET, DOXYCYCLINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6106891-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 20, 2009. Male patient, 55 years of age, weighting 180.0 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bacteria stool identified, culture stool positive, diarrhoea, neutropenia. Erlotinib dosage: unknown. During the same period patient was treated with ARQ, ACIPHEX, LOTREL, ADVAIR HFA, NEURONTIN, ZOLOFT, COUMADIN, METFORMIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5426090-5
Erlotinib side effect was reported by a Pharmacist from UNITED STATES on Aug 23, 2007. Female patient, 54 years of age, weighting 96.12 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea. Erlotinib dosage: 150 MG PO QD. During the same period patient was treated with LEVOTHYROXINE, METOPROLOL SUCCINATE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5921246-7
Erlotinib side effect was reported by a Physician from ISRAEL on Sept 29, 2008. Female patient, 81 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, hyperkalaemia. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with PROCOR, NORMITEN, PRIMIDONE, CARTIA. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5518470-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 13, 2007. Female patient, 78 years of age, weighting 184.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, diarrhoea, headache
, nausea . Erlotinib dosage: 150 MG DAILY 047. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5638851-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 22, 2008. Female patient, 78 years of age, weighting 184.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, diarrhoea, headache
, nausea . Erlotinib dosage: 150 MG DAILY 047. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6060242-9
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on Jan 14, 2009. Male patient, 78 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypotension, lower respiratory tract infection, malignant neoplasm progression, non-small cell lung cancer, pneumonia
. Erlotinib dosage: (150 MG, QD) ,ORAL. Patient was hospitalized. Patient died on 01/01/2009.Erlotinib Side Effects Report #5192756-8
Erlotinib side effect was reported by a Physician from VENEZUELA on Dec 04, 2006. Female patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, dyspnoea, respiratory tract infection. Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5387522-4
Erlotinib side effect was reported by a Physician from GERMANY on June 27, 2007. Female patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: colitis ischaemic, dermatitis bullous, diarrhoea, dry mouth, staphylococcal sepsis. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with ALLOPURINOL, OXYBUTYNIN CHLORIDE, KARVEZIDE, ASPIRIN. Patient was hospitalized. Patient died on 01/28/2007.
Erlotinib Side Effects Report #5529998-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 12, 2007. Female patient, 75 years of age, weighting 151.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain lower, diarrhoea, differential white blood cell count abnormal, disease progression, diverticulum intestinal, gallbladder disorder, haematocrit decreased, haemoglobin decreased, lymphadenopathy mediastinal. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE, NORVASC, BENAZEPRIL, LEXAPRO, DETROL, CLIRINEX, HYDROCHLOROTHIAZIDE, IRON POLYSACCHARIDE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5710611-9
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 01, 2008. Female patient, 75 years of age, weighting 151.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain lower, anaemia, diarrhoea, diverticulum, dyspnoea, fatigue, gallbladder disorder, haematocrit decreased, haemoglobin decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE, NORVASC, BENAZEPRIL, LEXAPRO, DETROL, CLARINEX, HYDROCHLOROTHIAZIDE, IRON POLYSACCHARIDE. Patient was hospitalized and became disabled. Patient recovered.
Erlotinib Side Effects Report #5776185-1
Erlotinib side effect was reported by a Physician from AUSTRALIA on May 29, 2008. Male patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, diarrhoea, haemoglobin increased, hypomagnesaemia, neutropenia, somnolence, thrombocytopenia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with ASPIRIN, METFORMIN, MELIZIDE, PERINDOPRIL ERBUMINE, SIMVASTATIN, LOPERAMIDE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6140652-1
Erlotinib side effect was reported by a Physician from VENEZUELA on Mar 16, 2009. Female patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, respiratory tract infection. Erlotinib dosage: 150 MG (150 MG, QD), ORAL. Patient was hospitalized. Patient died on 11/22/2006.
Erlotinib Side Effects Report #5235111-4
Erlotinib side effect was reported by a Physician from POLAND on Jan 23, 2007. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain upper, diarrhoea, fatigue. Erlotinib dosage: unknown. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5386371-0
Erlotinib side effect was reported by a Physician from UNITED KINGDOM on June 25, 2007. Female patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, oral intake reduced, rash
. Erlotinib dosage: unknown. Patient died.Erlotinib Side Effects Report #5897649-6
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 08, 2008. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, hypoglycaemia, rash
. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with GLYBURIDE, ADALAT, GLUCOBAY, INDERAL, OLMETEC, LIPITOR, ROHYPNOL, DEPAS. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5918087-3
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 26, 2008. Female patient, 74 years of age, weighting 123.5 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activities of daily living impaired, blood pressure decreased, diarrhoea, feeling abnormal, loss of consciousness, paronychia, rash
. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with AMLODIPINE BESYLATE, OLMETEC. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6023266-3
Erlotinib side effect was reported by a Consumer or non-health professional from JAPAN on Dec 09, 2008. Female patient, 74 years of age, weighting 123.5 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, disease complication, feeling abnormal, loss of consciousness, paronychia. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with AMLODIPINE BESYLATE, OLMETEC. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6088065-5
Erlotinib side effect was reported by a Physician from JAPAN on Feb 06, 2009. Female patient, 74 years of age, weighting 77.16 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, disease recurrence, haemoptysis. Erlotinib dosage: (100 MG, QD) ,ORAL. During the same period patient was treated with PROTECADIN, MUCOSTA, ASTOMIN. Patient recovered.
Erlotinib Side Effects Report #5400121-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on July 27, 2007. Female patient, 71 years of age, weighting 148.4 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abasia, asthenia, back pain
, constipation , dehydration, diarrhoea, failure to thrive, hypokalaemia. Erlotinib dosage: 150 MG QD PO. Patient died on 07/24/2007.Erlotinib Side Effects Report #5648138-5
Erlotinib side effect was reported by a Physician from JAPAN on Feb 14, 2008. Female patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaphylactic shock, diarrhoea, loss of consciousness, pleural effusion. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with PICIBANIL, UNASYN, BISOPROLOL FUMARATE, HALCION, ENTERONON, SUNRYTHM. Patient recovered.
Erlotinib Side Effects Report #6023554-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Dec 26, 2008. Male patient, 71 years of age, weighting 156.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, dehydration, diarrhoea, liver function test abnormal, pyrexia, renal failure acute, rhabdomyolysis. Erlotinib dosage: 150 MG DAILY 047 PO. During the same period patient was treated with BEVACIZUMAB, ZOFRAN, FENTANYL, MARINOL, RELISTOR, CORTISONE ACETATE, SYTHROID, TRAZODONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6028903-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 05, 2009. Male patient, 71 years of age, weighting 156.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, dehydration, diarrhoea, faecal incontinence, lethargy, liver function test abnormal, pyrexia, renal failure acute, rhabdomyolysis. Erlotinib dosage: 150 MG DAILY 047 PO. During the same period patient was treated with BEVACIZUMAB, ZOFRAN, FENTANYL, MARINOL, RELISTOR, CORTISONE ACETATE, SYTHROID, TRAZODONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6055347-2
Erlotinib side effect was reported by a Physician from UNITED STATES on Jan 08, 2009. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, faecal incontinence, lethargy, renal failure acute, rhabdomyolysis, somnolence, unresponsive to stimuli. Erlotinib dosage: 150 MG QD ORAL; 150 MG ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6071446-3
Erlotinib side effect was reported by a Physician from UNITED STATES on Jan 21, 2009. Male patient, 71 years of age, weighting 157.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, faecal incontinence, loss of consciousness, renal failure acute, rhabdomyolysis. Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with BEVACIZUMAB, ZOFRAN, FENTANYL, MARINOL, CORTISONE, SYNTHROID, TRAZODONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #4738431-2
Erlotinib side effect was reported by a Physician from PERU on July 22, 2005. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration, diarrhoea, hypovolaemic shock, multi-organ failure, rash
. Erlotinib dosage: 150 MG (QD) ORAL. During the same period patient was treated with ISOSORBIDE DINITRATE, CAPTOPRIL, FUROSEMIDE. Patient was hospitalized. Patient died on 04/22/2005.Erlotinib Side Effects Report #5012296-6
Erlotinib side effect was reported by a Physician from PERU on May 10, 2006. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration, diarrhoea, hypovolaemic shock, multi-organ failure, rash
. Erlotinib dosage: unknown. During the same period patient was treated with ISOSORBIDE DINITRATE, CAPTOPRIL, FUROSEMIDE. Patient was hospitalized. Patient died on 04/22/2005.Erlotinib Side Effects Report #5034583-8
Erlotinib side effect was reported by a Physician from PERU on May 23, 2006. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration, diarrhoea, hypovolaemic shock, multi-organ failure, performance status decreased, rash
. Erlotinib dosage: 150 MG 1 X PER DAY / ORAL. During the same period patient was treated with ISOSORBIDE DINITRATE, CAPTOPRIL, FUROSEMIDE. Patient died.Erlotinib Side Effects Report #5034654-6
Erlotinib side effect was reported by a Physician from PERU on June 05, 2006. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration, diarrhoea, hypovolaemic shock, multi-organ failure, performance status decreased, rash
. Erlotinib dosage: unknown. During the same period patient was treated with ISOSORBIDE DINITRATE, CAPTOPRIL, FUROSEMIDE. Patient was hospitalized. Patient died on 04/22/2005.Erlotinib Side Effects Report #5420775-2
Erlotinib side effect was reported by a Health Professional from HUNGARY on July 31, 2007. Female patient, 70 years of age, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, body temperature increased, bronchitis , diarrhoea, nephrolithiasis, viral infection . Erlotinib dosage: 150 MG (QD),ORAL. During the same period patient was treated with PEMETREXED, THEOPHYLLINE, SALBUTEROL, SPIRIVA, FLUTICASONE PROPIONATE, FOLIC ACID, VITAMIN B12, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5451867-X
Erlotinib side effect was reported by a Consumer or non-health professional from HUNGARY on Aug 29, 2007. Female patient, 70 years of age, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, bronchitis , diarrhoea, nephrolithiasis, viral infection . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with PEMETREXED, THEOPHYLLINE, SALABUTEROL, SPIRIVA, FLUTICASONE PROPIONATE, FOLIC ACID, VITAMIN B12, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5488664-5
Erlotinib side effect was reported by a Health Professional from HUNGARY on Oct 01, 2007. Female patient, 70 years of age, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchitis
, diarrhoea, nephrolithiasis, viral infection . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with PEMETREXED, THEOPHYLLINE, SALBUTEROL, SPIRIVA, FLUTICASONE PROPIONATE, FOLIC ACID, VITAMIN B12, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5836131-9
Erlotinib side effect was reported by a Consumer or non-health professional from on July 22, 2008. Male patient, 70 years of age, weighting 277.8 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, candidiasis, diarrhoea, nausea
, neutrophil count decreased, sleep disorder . Erlotinib dosage: 150 MG QD, ORAL. During the same period patient was treated with PEMETREXED, FOLIC ACID, VITAMIN B12, DEXAMETHASONE, FUROSEMIDE, METOPROLOL TARTRATE, SPIRIVA, VIANI. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6063627-X
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 14, 2009. Male patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activities of daily living impaired, aphonia, cough, diarrhoea, diplopia, disease progression, nausea
, optic ischaemic neuropathy, rash . Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PEMETREXED, DEXAMETHASONE, COMPAZINE, FOLIC ACID. Patient recovered.Erlotinib Side Effects Report #5765547-4
Erlotinib side effect was reported by a Physician from HUNGARY on May 20, 2008. Male patient, 69 years of age, weighting 149.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, duodenal ulcer, erosive duodenitis, neoplasm progression, neutropenia, reflux oesophagitis, thrombocytopenia. Erlotinib dosage: 150 MG (150 MG, QD), ORAL. During the same period patient was treated with PEMETREXED, SALBUTAMOL, TITROPIUM BROMIDE, FORMOTEROL, PERINDOPRIL ERBUMINE, FUROSEMIDE, FAMOTIDINE, FOLIC ACID. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5902507-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 11, 2008. Male patient, 69 years of age, weighting 183.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, disease progression, dyspnoea exertional, haemoptysis, increased upper airway secretion, liver disorder, lung disorder, malaise, nausea
. Erlotinib dosage: (150 MG, QD), ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6125590-2
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 13, 2009. Male patient, 69 years of age, weighting 136.7 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain
, atrial fibrillation , blood potassium decreased, dehydration, diarrhoea, leukopenia, performance status decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with ARQ, BISOPROLOL FUMARATE, OMEPRAZOLE. Patient was hospitalized and became disabled. Patient died on 02/28/2009.Erlotinib Side Effects Report #5999452-5
Erlotinib side effect was reported by a Physician from GERMANY on Nov 26, 2008. Female patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, rotavirus infection
. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with TRAMADOL HYDROHLORIDE, PANTOPRAZOLE, NOVALGIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6024147-1
Erlotinib side effect was reported by a Physician from GERMANY on Dec 17, 2008. Female patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, diarrhoea, erythema, gamma-glutamyltransferase increased, hepatotoxicity, malignant neoplasm progression, non-small cell lung cancer. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with TRAMADOL HYDROHLORIDE, PANTOPRAZOLE, NOVALGIN, VOLTAREN, ECURAL. Patient was hospitalized. Patient died on 11/24/2008.
Erlotinib Side Effects Report #6055041-8
Erlotinib side effect was reported by a Physician from ITALY on Jan 16, 2009. Female patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atrial fibrillation
, cardiac failure acute, dehydration, diarrhoea, renal failure. Erlotinib dosage: unknown. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5862118-6
Erlotinib side effect was reported by a Health Professional from JAPAN on Aug 11, 2008. Female patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, haematochezia, shock haemorrhagic. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with LOXONIN, MUCOSAL, MUCODYNE. Patient died on 04/17/2008.
Erlotinib Side Effects Report #5900831-2
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 11, 2008. Female patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, haematochezia, shock haemorrhagic. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with LOXONIN, MUCOSAL, MUCODYNE. Patient died on 04/17/2008.
Erlotinib Side Effects Report #5940771-6
Erlotinib side effect was reported by a Pharmacist from UNITED STATES on Nov 03, 2008. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, hepatic enzyme increased. Erlotinib dosage: 150 MG EVERY DAY PO. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6060234-X
Erlotinib side effect was reported by a Health Professional from BELGIUM on Jan 16, 2009. Female patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, dizziness
, nausea , oral fungal infection, renal failure acute, weight decreased. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with REPAGLINIDE, NEBIVOLOL, TIOTROPIUM, ENOXAPARIN, SERETIDE, ALLOPURINOL, SIMVASTATIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5216929-0
Erlotinib side effect was reported by a Physician from SWITZERLAND on Nov 17, 2006. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, gastrointestinal haemorrhage, gastrointestinal inflammation. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5237023-9
Erlotinib side effect was reported by a Physician from SWEDEN on Jan 26, 2007. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, diarrhoea, haemoptysis, lung neoplasm malignant, malignant neoplasm progression, malnutrition, nausea
, performance status decreased. Erlotinib dosage: 150 MG, ORAL. During the same period patient was treated with OXYCONTIN, PREDNISOLONE, ACETAMINOPHEN, COZAAR, METOPROLOL TARTRATE, KLEXANE, IMOVANE, OXYCODONE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5526191-7
Erlotinib side effect was reported by a Physician from SWEDEN on Nov 06, 2007. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, lung neoplasm malignant, malignant neoplasm progression, malnutrition, metastases to bone, nausea
, pain . Erlotinib dosage: 150 MG (150 MG,QD), ORAL. During the same period patient was treated with OXYCONTIN, PREDNISONE, ACETAMINOPHEN, COZAAR, METOPROLOL TARTRATE, ENOXAPARIN, IMOVANE, OXYCODONE. Patient was hospitalized. Patient died on 01/18/2007.Erlotinib Side Effects Report #5262258-9
Erlotinib side effect was reported by a Pharmacist from UNITED STATES on Mar 08, 2007. Male patient, 63 years of age, weighting 218.3 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood bilirubin increased, diarrhoea, liver function test abnormal. Erlotinib dosage: 150 MG ONCE DAILY PO. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5535090-6
Erlotinib side effect was reported by a Physician from CANADA on Nov 16, 2007. Female patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, diarrhoea, disease progression, hypotension, somnolence. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with PIOGLITAZONE, RABEPRAZOLE, TRAZODONE, LEVOTHYROXINE, PAROXETINE, EPREX, CIPROFLOXACIN, LOPERAMIDE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5930424-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 14, 2008. Male patient, 62 years of age, weighting 147.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood sodium decreased, blood urea increased, dehydration, diarrhoea, fatigue, hyperuricaemia. Erlotinib dosage: (150 MG), ORAL. During the same period patient was treated with VALIUM, FOLIC ACID, HYDROXYCHLOROQUINE SULPHATE, PERCOCET, PROCHLORPERAZINE MALEATE, PREDNISONE, BENAZEPRIL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5956177-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 30, 2008. Male patient, 62 years of age, weighting 147.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood sodium decreased, blood urea increased, dehydration, diarrhoea, fatigue, hyperuricaemia. Erlotinib dosage: (150 MG), ORAL. During the same period patient was treated with VALIUM, FOLIC ACID, HYDROXYCHLOROQUINE SULPHATE, PERCOCET, PROCHLORPERAZINE MALEATE, PREDNISONE, BENAZEPRIL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5332130-4
Erlotinib side effect was reported by a Physician from UNITED STATES on May 03, 2007. Female patient, 61 years of age, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood calcium decreased, blood creatinine increased, blood phosphorus increased, diarrhoea, febrile neutropenia, haemoglobin decreased, hypokalaemia. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5259639-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 20, 2007. Male patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, dizziness
, dyspnoea exertional, gait disturbance, movement disorder , nausea , oesophageal pain. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5320160-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 18, 2007. Male patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cytomegalovirus oesophagitis, dehydration, diarrhoea, dizziness
, dyspnoea exertional, gait disturbance, movement disorder , nausea . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6058039-9
Erlotinib side effect was reported by a Physician from JAPAN on Jan 16, 2009. Male patient, 58 years of age, weighting 136.7 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, candidiasis, cough, crepitations, diarrhoea, disease progression, dyspnoea, hepatic cancer metastatic. Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with FUDOSTEINE, NOVAMIN, FENTANYL, ITRACONAZOLE, CODEINE PHOSPHATE. Patient died on 12/24/2008.
Erlotinib Side Effects Report #5138648-1
Erlotinib side effect was reported by a Physician from UNITED STATES on Oct 09, 2006. Female patient, 52 years of age, weighting 123.7 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, granulocytes abnormal, neutrophil count abnormal, pulmonary embolism
. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, AMITRIPTYLINE, FLUOXETINE, SUMATRIPTAN SUCCINATE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5506949-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 18, 2007. Male patient, 52 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood albumin decreased, blood alkaline phosphatase increased, condition aggravated, dehydration, diarrhoea, lung cancer metastatic, pneumonia
. Erlotinib dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5739357-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 29, 2008. Male patient, 52 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood albumin decreased, blood alkaline phosphatase increased, dehydration, diarrhoea, metastases to lung, pneumonia
, pyrexia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with HYDROCODONE, ACETAMINOPHEN, DIPHENHYDRAMINE, CEPHALEXIN, IBUPROFEN, LOPERAMIDE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5875062-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Sept 08, 2008. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: clostridium difficile toxin test positive, dehydration, diarrhoea, haemoglobin decreased, nausea
, pyrexia. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5885500-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Sept 15, 2008. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: clostridium difficile toxin test positive, dehydration, diarrhoea, haemoglobin decreased, nausea
, pyrexia. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5910478-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Oct 06, 2008. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chills, clostridium difficile colitis, dehydration, diarrhoea, nausea
, pyrexia. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5944242-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 20, 2008. Male patient, 47 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: clostridium difficile colitis, dehydration, diarrhoea, haemoglobin decreased, nausea
, pseudomembranous colitis, pyrexia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6073105-X
Erlotinib side effect was reported by a Health Professional from CANADA on Feb 02, 2009. Female patient, 45 years of age, weighting 135.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, hypocalcaemia, hypomagnesaemia, nausea
. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with HUMULIN N, HUMULIN R, PERINDOPRIL ERBUMINE, CETIRIZINE, CRESTOR, ASPIRIN, PAROXETINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6088067-9
Erlotinib side effect was reported by a Health Professional from CANADA on Feb 06, 2009. Female patient, 45 years of age, weighting 135.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, hypocalcaemia, hypomagnesaemia, malaise, nausea
. Erlotinib dosage: (150 MG, QD) ,ORAL; (100 MG, QD) ,ORAL. During the same period patient was treated with HUMULIN M, HUMULIN R, PERINDOPRIL ERBUMINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5494757-9
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 23, 2007. Female patient, weighting 180.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, diarrhoea, headache
, nausea . Erlotinib dosage: 150 MG DAILY 047. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5532778-8
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 30, 2007. Female patient, weighting 140.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, enterocolitis infectious, gastrointestinal haemorrhage, lower gastrointestinal haemorrhage. Erlotinib dosage: 150MG ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5562710-2
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 11, 2007. Female patient, weighting 140.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, enterocolitis infectious, gastroenteritis
, lower gastrointestinal haemorrhage. Erlotinib dosage: 150MG ORALLY QD. During the same period patient was treated with DASATINIB, ETODOLAC, NAPROSYN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5985905-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Dec 08, 2008. Male patient, weighting 156.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: body temperature increased, dehydration, diarrhoea. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6084839-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 04, 2009. Female patient, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, dehydration, diarrhoea, dyspnoea, hyperkalaemia, hypokalaemia, hypophosphataemia, neutrophilia, vomiting. Erlotinib dosage: (150 MG, QD) ,ORAL. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6120262-2
Erlotinib side effect was reported by a Physician from UNITED STATES on Mar 04, 2009. Female patient, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, dyspnoea, hyperkalaemia, hypokalaemia, hypophosphataemia, neutrophilia, renal failure. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient died on 02/17/2009.
Erlotinib Side Effects Report #6137759-1
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 11, 2009. Male patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: body temperature decreased, dehydration, diarrhoea, fatigue, hypomagnesaemia, rash
, renal failure acute, renal impairment, thirst. Erlotinib dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #4663266-9
Erlotinib side effect was reported by a Physician from on Apr 29, 2005. Male patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, hypovolaemic shock, multi-organ disorder, rash
. Erlotinib dosage: unknown. During the same period patient was treated with ISOSORBIDE DINITRATE, CAPTOPRIL, FUROSEMIDE. Patient was hospitalized. Patient died on 04/23/2005.Erlotinib Side Effects Report #5259650-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 20, 2007. Male patient, 71 years of age, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atrial fibrillation
, atrial flutter, bacteraemia, bacterial infection , beta haemolytic streptococcal infection, blood pressure increased, cerebral infarction, diarrhoea, embolic stroke. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with CISPLATIN, DOCETAXEL, IMODIUM, HYDROCODONE, DEXAMETHASONE, ZOFRAN. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5088388-2
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 08, 2006. Male patient, 71 years of age, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, mental status changes, neck pain, radical neck dissection. Erlotinib dosage: 150 MG (QD),ORAL. During the same period patient was treated with CISPLATIN, DOCETAXEL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5108432-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Aug 30, 2006. Male patient, 71 years of age, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atrial fibrillation
, atrial flutter, bacteraemia, blood pressure systolic increased, diarrhoea, embolic stroke, encephalitis , meningitis , pneumonia aspiration. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with CISPLATIN, DOCETAXEL, IMODIUM, HYDROCODONE, DEXAMETHASONE, ZOFRAN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5750274-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 20, 2008. Male patient, weighting 183.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea. Erlotinib dosage: 150 MG, QD, PO. During the same period patient was treated with RAPAMUNE, FOSAMAX, BENZACLIN, VITAMIN B, DICLOMYME, LOMOTIL, DOXAZOS, FINASTERIDE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5442832-7
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 28, 2007. Female patient, 79 years of age, weighting 101.0 lb, was diagnosed with metastatic neoplasm, neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, dysphagia, dyspnoea, vomiting. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5578433-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 10, 2007. Female patient, 79 years of age, weighting 101.0 lb, was diagnosed with metastatic neoplasm, neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, blood sodium decreased, blood urea increased, blood urea nitrogen/creatinine ratio increased, breath sounds abnormal, constipation
, dehydration, diarrhoea, dysphagia. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.